Declining exposures to lead and cadmium contribute to explaining the reduction of cardiovascular mortality in the US population, 1988-2004

International Journal of Epidemiology

Volumn 46, Issue 6, 2017, Pages 1903-1912

  Ruiz Hernandez, Adrian ^a,b   Navas Acien, Ana ^c,d   Pastor Barriuso, Roberto ^e,f   Crainiceanu, Ciprian M ^d   Redon, Josep ^a,b,g   Guallar, Eliseo ^c,d   Tellez Plaza, Maria ^b,d  

^a Clinic Hospital of Valencia   (Spain)

^b Instituto Universitario IVI INCLIVA   (Spain)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e CARLOS III INSTITUTE OF HEALTH   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g Instituto de Salud Carlos III   (Spain)

Author keywords

Cadmium; Cardiovascular mortality; Lead; NHANES; Trends

Indexed keywords

CADMIUM; LEAD;

ADULT; BIOACCUMULATION; BLOOD; CADMIUM; CARDIOVASCULAR DISEASE; CONCENTRATION (COMPOSITION); ENVIRONMENTAL MONITORING; HEALTH POLICY; HEALTH RISK; HEALTH SURVEY; LEAD; MORTALITY; POLICY IMPLEMENTATION; POLLUTION EXPOSURE; PUBLIC HEALTH; RISK FACTOR; TREND ANALYSIS; URINE;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; FEMALE; HEALTH SURVEY; HUMAN; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES; URINE LEVEL; AGE DISTRIBUTION; AGED; BLOOD; CARDIOVASCULAR DISEASE; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; NUTRITION; SEX RATIO; STATISTICAL MODEL; URINE;

UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; CADMIUM; CARDIOVASCULAR DISEASES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; LEAD; LINEAR MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PROSPECTIVE STUDIES; SEX DISTRIBUTION; UNITED STATES;

EID: 85039548062     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyx176     Document Type: Article

References (55)

1. Cooper R, Cutler J, Desvigne-Nickens P et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the National Conference on Cardiovascular Disease Prevention. Circulation 2000;102: 3137-47
2. Roger VL. Cardiovascular diseases in populations: secular trends and contemporary challenges-Geoffrey Rose lecture, European Society of Cardiology meeting 2014. Eur Heart J 2015;36: 2142-46
3. Tellez-Plaza M, Navas-Acien A, Caldwell KL, Menke A, Muntner P, Guallar E. Reduction in cadmium exposure in the United States population, 1988-2008: the contribution of declining smoking rates. Environ Health Perspect 2012;120:204-09
4. Muntner P, Menke A, DeSalvo KB, Rabito FA, Batuman V. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med 2005;165:2155-61
5. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. Lead exposure and cardiovascular disease-a systematic review. Environ Health Perspect 2007;115:472-82
6. Tellez-Plaza M, Jones MR, Dominguez-Lucas A, Guallar E, Navas-Acien A. Cadmium exposure and clinical cardiovascular disease: a systematic review. Curr Atheroscler Rep 2013;15:356
7. Almenara CCP, Broseghini-Filho GB, Vescovi MVA et al. Chronic cadmium treatment promotes oxidative stress and endothelial damage in isolated rat aorta. PLoS One 2013;8:e68418
8. Angeli JK, Cruz Pereira CA, de Oliveira Faria T, Stefanon I, Padilha AS, Vassallo DV. Cadmium exposure induces vascular injury due to endothelial oxidative stress: the role of local angiotensin II and COX-2. Free Radic Biol Med 2013;65:838-48
9. Knoflach M, Messner B, Shen YH et al. Non-toxic cadmium concentrations induce vascular inflammation and promote atherosclerosis. Circ J 2011;75:2491-95
10. Messner B, Bernhard D. Cadmium and cardiovascular diseases: cell biology, pathophysiology, and epidemiological relevance. Biometals 2010;23:811-22
11. Cosselman KE, Navas-Acien A, Kaufman JD. Environmental factors in cardiovascular disease. Nat Rev Cardiol 2015;12: 627-42
12. Lange T, Hansen JV. Direct and indirect effects in a survival context. Epidemiology 2011;22:575-81
13. Centers for Diseases Control and Prevention (CDC), National Centers for Health Statistics (NCHS). NHANES-National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes.htm (15 April 2016, date last accessed)
14. Paschal DC, Burt V, Caudill SP et al. Exposure of the U.S. population aged 6 years and older to cadmium: 1988-1994. Arch Environ Contam Toxicol 2000;38:377-83
15. Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, Sharrett AR, Guallar E. Cadmium and peripheral arterial disease: gender differences in the 1999-2004 US national health and nutrition examination survey. Am J Epidemiol 2010;172:671-681
16. World Health Organization (WHO). International Classification of Diseases (ICD-10). http://www.who.int/classifications/icd/en/(15 April 2016, date last accessed)
17. Jiang Z, VanderWeele TJ. When is the difference method conservative for assessing mediation? Am J Epidemiol 2015;182: 105-08
18. VanderWeele TJ. Causal mediation analysis with survival data. Epidemiology 2011;22:582-85
19. Hense HW, Filipiak B, Novak L, Stoeppler M. Nonoccupational determinants of blood lead concentrations in a general population. Int J Epidemiol 1992;21:753-62
20. Apostolou A, Garcia-Esquinas E, Fadrowski JJ, McLain P, Weaver VM, Navas-Acien A. Secondhand tobacco smoke: a source of lead exposure in US children and adolescents. Am J Public Health 2012;102:714-22
21. Agency for Toxic Substances and Disease Registry (ATSDR)-Toxicological Profile: Lead. 2007. http://www.atsdr.cdc.gov/tox profiles/tp.asp?id=96&tid=22 (15 April 2016, date last accessed)
22. Agency for Toxic Substances and Disease Registry (ATSDR)-Toxicological Profile: Cadmium. 2012. http://www.atsdr.cdc. gov/toxprofiles/tp.asp?id=48&tid=15 (15 April 2016, date last accessed)
23. Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Working Group views and expert opinions, Lyon, 9-16 February 1993. IARC Monogr Eval Carcinog Risks Hum 1993;58:1-415
24. U.S. Geological Survey. Minerals Information: Cadmium. http://minerals.usgs.gov/minerals/pubs/commodity/cadmium/(15 April 2016, date last accessed)
25. Hogervorst J, Plusquin M, Vangronsveld J et al. House dust as possible route of environmental exposure to cadmium and lead in the adult general population. Environ Res 2007;103:30-37
26. Pirkle JL. The decline in blood lead levels in the United States. JAMA: American Medical Association 1994;272:284
27. U.S. Environmental Protection Agency, Office of Air Quality Planning and Standards. Lead j AirTrends j Air & Radiation j EPA. http://www3.epa.gov/airtrends/lead.html (15 April 2016, date last accessed)
28. Messner B, Knoflach M, Seubert A et al. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol 2009;29: 1392-98
29. Valko M, Morris H, Cronin MTD. Metals, toxicity and oxidative stress. Curr Med Chem 2005;12:1161-1208
30. Jin T, Lu J, Nordberg M. Toxicokinetics and biochemistry of cadmium with special emphasis on the role of metallothionein. Neurotoxicology 1998;19:529-35
31. Vaziri ND. Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol 2008;295: H454-65
32. Kamal M, Fathy MM, Taher E, Hasan M, Tolba M. Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers. Ann Saudi Med 2011;31:481-87
33. Ruiz-Hernandez A, Kuo C-C, Rentero-Garrido P et al. Environmental chemicals and DNA methylation in adults: a systematic review of the epidemiologic evidence. Clin Epigenetics 2015;7:55
34. Iavicoli I, Fontana L, Bergamaschi A. The effects of metals as endocrine disruptors. J Toxicol Environ Health B Crit Rev 2009; 12:206-23
35. Everett CJ, Frithsen IL. Association of urinary cadmium and myocardial infarction. Environ Res 2008;106:284-86
36. Lee M-S, Park SK, Hu H, Lee S. Cadmium exposure and cardiovascular disease in the 2005 Korea National Health and Nutrition Examination Survey. Environ Res 2011;111:171-76
37. Gustavsson P, Plato N, Hallqvist J et al. A population-based case-referent study of myocardial infarction and occupational exposure to motor exhaust, other combustion products, organic solvents, lead, and dynamite. Stockholm Heart Epidemiology Program (SHEEP) Study Group. Epidemiology 2001;12:222-28
38. Kosmala W, Kuliczkowski W, Jolda-Mydlowska B, Przewlocka-Kosmala M, Kucharski W, Antonowicz-Juchniewicz J. Relation between heavy metals and left ventricular diastolic function in patients with coronary artery disease. Toxicol Mech Methods 2004;14:177-82
39. Pocock SJ, Shaper AG, Ashby D, Delves HT, Clayton BE. The relationship between blood lead, blood pressure, stroke, and heart attacks in middle-aged British men. Environ Health Perspect 1988;78:23-30
40. Kromhout D. Blood lead and coronary heart disease risk among elderly men in Zutphen, the Netherlands. Environ Health Perspect 1988;78:43-46
41. Tellez-Plaza M, Guallar E, Howard BVet al. Cadmium exposure and incident cardiovascular disease. Epidemiology 2013;24: 421-29
42. Peters JL, Perlstein TS, Perry MJ, McNeely E, Weuve J. Cadmium exposure in association with history of stroke and heart failure. Environ Res 2010;110:199-206
43. Borné Y, Barregard L, Persson M, Hedblad B, Fagerberg B, Engström G. Cadmium exposure and incidence of heart failure and atrial fibrillation: a population-based prospective cohort study. BMJ Open 2015;5:e007366
44. Navas-Acien A, Silbergeld EK, Sharrett R, Calderon-Aranda E, Selvin E, Guallar E. Metals in urine and peripheral arterial disease. Environ Health Perspect 2005;113:164-69
45. Tellez-Plaza M, Guallar E, Fabsitz RR et al. Cadmium exposure and incident peripheral arterial disease. Circ Cardiovasc Qual Outcomes 2013;6:626-33
46. Pan TC, Horng CJ, Lin SR, Lin TH, Huang CW. Simultaneous determination of Zn, Cd, Pb, and Cu in urine of patients with blackfoot disease using anodic stripping voltammetry. Biol Trace Elem Res 1993;38:233-41
47. Fagerberg B, Bergström G, Borén J, Barregard L. Cadmium exposure, intercellular adhesionmolecule-1 and peripheral artery disease: a cohort and an experimental study. BMJOpen 2013;3:e002489
48. Fagerberg B, Barregard L, Sallsten G et al. Cadmium exposure and atherosclerotic carotid plaques-results from the Malmödiet and Cancer study. Environ Res 2015;136:67-74
49. Fagerberg B, Bergström G, Borén J, Barregard L. Cadmium exposure is accompanied by increased prevalence and future growth of atherosclerotic plaques in 64-year-old women. J Intern Med 2012;272:601-10
50. Lamas GA, Goertz C, Boineau R et al. Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA 2013;309:1241-50
51. Ouyang P, Gottlieb SH, Culotta VL, Navas-Acien A. EDTA chelation therapy to reduce cardiovascular events in persons with diabetes. Curr Cardiol Rep 2015;17:96
52. Lamas GA, Navas-Acien A, Mark DB, Lee KL. Heavy metals, cardiovascular disease, and the unexpected benefits of edetate chelation therapy. J Am Coll Cardiol 2016;67:2411-18
53. US Environmental Protection Agency, Office of Air Quality Planning and Standards. AirTrends j Air&Radiation j EPA. https://www3.epa.gov/airtrends/(15 April 2016, date last accessed)
54. Lange T, Rasmussen M, Thygesen LC. Assessing natural direct and indirect effects through multiple pathways. Am J Epidemiol 2014;179:513-18
55. VanderWeele TJ, Vansteelandt S. Mediation analysis with multiple mediators. Epidemiol Method 2014;2:95-115